Drug significantly reduces chorea symptoms in patients with Huntington's disease

The drug valbenazine statistically improves chorea, a movement disorder commonly associated with Huntington's disease, when compared to a placebo.

Related Keywords

United States ,American ,Furr Stimming ,Neurocrine Biosciences ,Drug Administration ,American Academy Of Neurology ,Huntington Disease Society Of America Center ,Clinical Research Inc ,Clinical Trials Coordination Center ,Mcgovern Medical School ,Huntington Study Group ,Huntington Disease Health Index ,University Of Rochester Medical Center ,Memorial Hermann Chair ,American Academy ,Disease Society ,America Center ,Disease Health Index ,New Drug Application ,Rochester Medical Center ,